Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials
- PMID: 3896460
- DOI: 10.1002/1097-0142(19851001)56:7<1710::aid-cncr2820560741>3.0.co;2-t
Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials
Abstract
The survival of 78 patients with resected non-small cell lung cancer entered in prospective, randomized investigational trials is compared to that of a population-based group of control patients not included in such trials. The survival of trial patients is significantly better than that of controls (P less than 0.001). This survival advantage for trial participants is most apparent among late Stage I patients, and is observed after matching for known prognostic factors (i.e., primary tumor size, nodal status, tumor histology) and after adjusting in the analysis for age, sex, and the administration of radiation therapy. Several explanations for the improved outcome for trial patients are explored, including differences in preoperative evaluation, staging, surgical technique, placebo effects, and patient motivation. These results suggest the possibility that inclusion in these controlled cancer trials may have had an inherent advantage for all participants.
Similar articles
-
Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).Eur J Cardiothorac Surg. 1998 Sep;14(3):256-62; discussion 263-4. doi: 10.1016/s1010-7940(98)00186-9. Eur J Cardiothorac Surg. 1998. PMID: 9761434
-
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.J Natl Cancer Inst. 1994 May 4;86(9):673-80. doi: 10.1093/jnci/86.9.673. J Natl Cancer Inst. 1994. PMID: 8158698 Clinical Trial.
-
Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.J Clin Oncol. 2015 Sep 1;33(25):2727-34. doi: 10.1200/JCO.2015.61.1517. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101240
-
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.Thorax. 2001 Aug;56(8):628-38. doi: 10.1136/thorax.56.8.628. Thorax. 2001. PMID: 11462066 Free PMC article. Review.
-
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.Lancet Oncol. 2014 Oct;15(11):1254-62. doi: 10.1016/S1470-2045(14)70402-4. Epub 2014 Sep 14. Lancet Oncol. 2014. PMID: 25232001 Review.
Cited by
-
From evidence to clinical practice in blood and marrow transplantation.Blood Rev. 2015 Nov;29(6):351-7. doi: 10.1016/j.blre.2015.04.001. Epub 2015 Apr 19. Blood Rev. 2015. PMID: 25934009 Free PMC article. Review.
-
Enrollment of extremely low birth weight infants in a clinical research study may not be representative.Pediatrics. 2012 Mar;129(3):480-4. doi: 10.1542/peds.2011-2121. Epub 2012 Feb 27. Pediatrics. 2012. PMID: 22371462 Free PMC article. Clinical Trial.
-
Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results.Br J Cancer. 2002 Aug 27;87(5):562-6. doi: 10.1038/sj.bjc.6600433. Br J Cancer. 2002. PMID: 12189557 Free PMC article.
-
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.Ther Adv Med Oncol. 2022 Mar 31;14:17588359221086813. doi: 10.1177/17588359221086813. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35386956 Free PMC article.
-
Comparison of clinical outcomes among cancer patients treated in and out of clinical trials.BMC Cancer. 2023 Aug 23;23(1):786. doi: 10.1186/s12885-023-11305-3. BMC Cancer. 2023. PMID: 37612602 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical